A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of FB825 in Healthy Volunteers
Clinical trial NCT02309762 · COMPLETED
Trial details
- NCT number
- NCT02309762
- Sponsor
- Fountain Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-02-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.